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Abstract
Background: Congenital cytomegalovirus (CMV) infection is the leading cause of sensorineural hearing loss (SNHL),
and SNHL is the most frequent sequela of congenital CMV infection. But the pathogenic mechanism remains
unknown, and there is no ideal CMV intrauterine infection animal model to study the mechanisms by which SNHL
develops.
Methods: We established the congenital murine cytomegalovirus (MCMV) infection model by directly injecting the
virus into the placenta on day 12.5 of gestation. Then, we observed the development and the MCMV congenital
infection rate of the fetuses on the day they were born. Furthermore, we detected the auditory functions, the
conditions of the MCMV infection, and the histological change of the inner ears of 28-day-old and 70-day-old offspring.
Results: Both the fetal loss rate and the teratism rate of offspring whose placentas were inoculated with MCMV
increased, and their body length, head circumference, and weight decreased. The hearing level of offspring both
decreased at both 28- and 70-days post birth; the 70-day-old mice developed lower hearing levels than did the
28-day old mice. No significant inflammatory changes in the cochleae of the mice were observed. MCMV DNA
signals were mainly detected in the spiral ganglion neurons and the endolymph area, but not in the perilymph
area. The number of neurons decreased, and their ultrastructures changed. Moreover, with age, the number of
neurons dramatically decreased, and the ultrastructural lesions of neurons became much more severe.
Conclusions: The results suggest that the direct injection of MCMV into the placenta may efficiently cause fetal
infection and disturb the intrauterine development of the fetus, and placental inoculation itself has no obvious
adverse effects on offspring. The reduction in the number of spiral ganglion neurons and the ultrastructural lesions
of the neurons may be the major cause of congenital CMV infection-induced progressive SNHL.
Background
Human cytomegalovirus (HCMV) is the most common
pathogen causing intrauterine infection in developing
countries [1]. Pregnant women are susceptible to pri-
mary and secondary HCMV infections. If a pregnant
woman is infected with HCMV, the virus can be trans-
mitted through the placenta or cervix, causing intrauter-
ine infection.
In developed countries, current estimates indicate that
[2,3] about 0.64% to 0.7% of all children are born with
HCMV. The incidence of HCMV is higher (1.2%) in socie-
ties with low socioeconomic status, regardless of whether
pregnant women are infected. Only 11% to 12.7% of chil-
dren with congenital HCMV infection exhibit clinical
signs at birth, such as petechia, hyperbilirubinemia, hepa-
tosplenomegaly, thrombocytopenia, chorioretinitis, sei-
zures, microencephaly, intracranial calcification, fetal
edema, etc. However, approximately 40% to 58% of chil-
dren with symptomatic infection and 13.5% of children
with asymptomatic infection develop long-term neurologi-
cal sequelae, including single- or two-sided progressive
sensorineural hearing loss (SNHL), cognitive deficit, and
motor deficit. In a clinical epidemiological study of 5,015
pregnant women and their children from big urban cen-
ters in China [4], we found that 5.42% of the pregnant
women were actively infected with HCMV and 37.32% of
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congenitally infected with the virus. The infected children
seem to be at higher risk for hearing loss, mental retarda-
tion, and other developmental anomalies of the nervous
system during infancy and childhood [5]. Li et al. [6]
found that the intellectual development, especially the lan-
guage skills development, of early childhood and preschool
children with asymptomatic intrauterine HCMV infection
is evidently lower than that of normal children. In addi-
tion, the pure-tone threshold of preschool children with
asymptomatic intrauterine HCMV infection is abnormal.
To date [7], it is believed that SNHL is the most fre-
quent sequela of congenital CMV infection and that
congenital CMV infection is the leading cause of SNHL.
Approximately 15%-25% of congenital hearing loss cases
in children are caused by intrauterine HCMV infection
[8-10] and 10%-20% of children with congenital CMV
infection exhibit varying degrees of hearing loss [11-13].
Theoretically, SNHL caused by intrauterine HCMV
infection may be closely related to inner ear diseases,
but the exact pathogenic mechanism remains unknown.
The pathogenic mechanism remains unknown primar-
ily because of the lack of an ideal animal model for
thorough studies. Similar to humans, the placenta of
guinea pigs has a single trophoblast layer that separates
maternal and fetal circulations. Hence, the guinea pig
cytomegalovirus (GPCMV) can cross the guinea pig pla-
centa, causing infection in utero [14,15]. However, the
relatively lengthy gestational periods (65-70 d) and the
lower-than-average litter size (2-4 newborn pups) of gui-
nea pigs [16] result in longer and, consequently, costly
experimental cycles. More importantly, the lack of avail-
able guinea pig immunological reagents critically ham-
pers the development of research on congenital
GPCMV infection and hearing loss.
In studying how intrauterine HCMV infection causes
SNHL, various models, including transgenic and knock-
out animals, are available. Mice have significantly
shorter gestational periods(19-21 d) and significantly
greater litter size (10-12 newborn pups). The murine
cytomegalovirus (MCMV) genome is highly similar to
the HCMV genome, and the characteristics of CMV
infection in mice are comparable to human CMV infec-
tion. Therefore, the congenital MCMV infection model
is highly useful in the development of research on
intrauterine CMV infection-induced hearing loss.
Two studies [17,18], utilizing the congenital GPCMV
infection model, have demonstrated the following: (a)
congenital GPCMV infection results in hearing loss and
severe labyrinthitis in newborns; and (b) GPCMV-
infected cells are mainly located in the perilymph area
and spiral ganglion, not in the endolymph area. How-
ever, the long-term pathology of congenitally infected
offspring, including ultrastructural changes remains
unknown. Moreover, no study has been conducted on
congenital CMV infection-induced hearing loss using
the murine model. The placental barrier is presumed to
be refractory to CMV transmission in mice because
murine placenta has a three-cell-thick trophoblast layer
that separates maternal and fetal circulations; hence, we
established a congenital murine cytomegalovirus infec-
tion model by directly injecting MCMV to the placenta,
as performed by Dr. Y Tsutsui [19]. We used the model
to observe the growth of offspring before and after
birth, especially the long-term auditory functions, the
conditions of the MCMV infection, and the long-term
histological changes of their inner ears. The purpose of
this study is to establish an ideal animal model of CMV
intrauterine infection, and use this model to prelimina-
rily study the possible mechanisms of MCMV congenital
infection-induced hearing loss.
Methods
Virus and cell cultures
The MCMV Smith strain was purchased from the
American Type Culture Collection (ATCC, VR-1399).
The strain was passaged in mouse embryonic fibroblasts
(MEF). MEF cells were prepared from 12-day-old
embryos of BALB/C mice and grown in Dulbecco’s
modified Eagle’s minimal essential medium (DMEM),
which contained penicillin (100 U/ml), streptomycin (50
ug/ml), and 10% fetal calf serum (FCS). The plaque
assay method of Wentworth and French was used to
quantify the virus. The titer of the virus stock was 1 ×
10
6 plaque-forming units (PFU)/ml. The virus samples
were stored in aliquots (-70°C), and each aliquot was
frozen and thawed only once.
Intraplacental infection of mouse embryos with MCMV
Specific-pathogen-free (SPF) BALB/C mice [12 ± 1 w,
22 ± 2 g (female), 26 ± 2 g (male)] were obtained from
Tongji Medical College of Huazhong University of
Science and Technology (Hubei, China). The mice with-
out MCMV infection [IgG(-) and IgM(-)], as identified
by enzyme-linked immunosorbent assay, served as sub-
jects. The male and female mice were placed in the
same cage at a male-female ratio of 1:2. The onset of
pregnancies, when copulation plugs were found after
overnight mating, was marked as day 0. Plugged females
were housed individually. On day 12.5 of gestation, the
pregnant mice were operated on under anesthesia with
10% chloral hydrate (350 mg/kg).
T h ep r e g n a n tm i c ew e r er a n d o m l yd i v i d e di n t o3
groups: the experimental group (n = 22), in which the
number of gestational sacs were counted, and then 1 ul
of the 1 × 10
6 per ml stock was injected into the placen-
tas using a microsyringe; the operation control group
(n = 24), in which the number of gestational sacs were
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into the placentas in the same way; and the blank con-
trol group (n = 24), in which the number of gestational
sacs was counted and no other actions were performed.
After the procedure, the fetuses of some pregnant
mice [experimental group (n = 12), operation control
group (n = 12), and blank control group (n = 12)] were
allowed to develop in uteru. They were surgically col-
lected on day 18.5 of gestation. We then observed the
conditions and the development of the intrauterine
infection. First, we counted the number of fetuses,
including the number of live fetuses and dead fetuses;
observed the abnormalities of the fetuses; measured the
body length, the head circumference, and the body
weight of the fetuses; and calculated the live birth rate,
the fetal loss rate, and the microcephalus rate. Second,
to detect the infection of the placentas and fetuses, we
amplified the MCMV DNA using the polymerase chain
reaction (PCR). The placentas, brains, lungs, livers, and
kidneys that were sterilely collected from the fetuses
were frozen at -70°C for DNA amplification using PCR.
The fetuses of other pregnant mice [experimental
group (n = 10), operation control group (n = 12), and
blank control group (n = 12)] were naturally delivered.
We then observed the auditory functions, the conditions
of the MCMV infection, and the histological changes of
the inner ears of 28-day-old and 70-day-old offspring.
All animal procedures were approved by the Interna-
tional Council on Laboratory Animal Science and were
conducted according to the Regulations for the Admin-
istration of Affairs Concerning Experimental Animals.
Amplification of viral DNA
With regard to the detection of the viral genome in
infected mice fetuses and placentas, specific DNA
sequences were amplified using PCR, as described by
Chen Li et al. [20]. Briefly, a set of oligonucleotide pri-
mers from exon 4 of the MCMV immediate-early (IE)
gene (GenBank accession number M11788) was
designed based on published sequence data [21]
. The
30-bp primer, which amplified a 700-bp segment of
MCMV, was used. The base sequences were as follows:
forward primer, 5’-ATC AAT CAG CCA TCA ACT
CTG CTA CCA CAC-3’ (exon 4 of the MCMV IE
cDNA 1701-1730); and reverse primer, 5’-ATG GTG
AAG CTA TCA AAG ATG TGC ATC TCA-3’ (exon 4
of the MCMV IE cDNA 2400-2371). Template DNA
was prepared through a series of phenol-chloroform
extractions, and 1 ug of sample DNA was added to the
reaction mixture (25 ul) before amplification. The final
concentrations of components in 25 ul of the PCR reac-
tion mixture were as follows: forward primer (0.5 ul),
reverse primer (0.5 ul), template DNA (1 ul), 2 × Mas-
terin (12.5 ul) [10 mM Tris-HCl (pH = 8.3), 50 mM
KCl, 1.5 mM MgCl2, 250 mM d NTP, and 1 ul Taq
DNA polymerase], and ddH2O (10.5 ul). PCR was per-
formed as follows: Step 1–10 min at 94°C × 1 cycle;
Step 2–1.5 min at 94°C, 1 min at 55°C, 2 min at 72°C ×
30 cycles; and Step 3–10 min at 72°C × 1 cycle and
soaked at 4°C. The products underwent electrophoresis
on 1.5% agarose gels, stained with ethidium bromide,
and photographed. Randomly selected PCR positive pro-
ducts were sent to Shanghai Sangon Company (Shang-
hai Sangon Biological Engineering Technology & Service
Corporation Ltd., Shanghai, China; lot number SK1322)
for DNA sequencing.
Auditory brainstem response
Auditory brainstem response (ABR) was assessed to
examine the effects of intrauterine MCMV infection in
the inner ears of infected mice. The fetuses of the three
groups were delivered naturally. The ABR of all off-
spring [experimental group (n = 33), randomly selected
fetuses of the operation control group (n = 40), and the
control group (n = 40)] were detected. Some of the off-
spring [experimental group (n = 16), operation control
group (n = 20), and blank control group (n = 20)] were
examined 28 d after delivery; the others [experimental
group (n = 17), operation control group (n = 20), and
blank control group (n = 20)] were examined 70 d after
delivery. Needle electrodes were placed subcutaneously
under tribromoethanol anesthesia (300 mg/kg, ip). For
each mouse, active electrodes were inserted beneath the
skin on top of the head, and the reference electrode was
inserted beneath the pinna of the measured ear and the
ground beneath the skin of the upper part of the nose.
The test used a rapid onset, transient click stimulus rate
of 11.1 clicks/second, lasting for 0.1 ms. Filter settings
were at 150-2000 Hz, with a gain of 1000. The scan
cycle was 10 ms. At the beginning of the test, the click
intensity was reduced to 10 dB sound pressure level
(SPL). The click intensity was reduced to 5 dB SPL
steps as it approached the threshold. The threshold was
defined as the lowest intensity level at which a clear
ABR waveform was visible in the evoked trace. This was
determined by visual inspection of the responses.
Pathological cochlear examination
After the ABR tests, the cochleae were separately taken
out under tribromoethanol anesthesia. Prior to the light
microscope analysis, the cochleae were perfused with 4%
paraformaldehyde and fixed for 24 h. After fixation, the
tissues were decalcified with 10% tetrasodium EDTA in
PBS (pH = 7.4) for 1 wk. The tissues were then dehy-
drated with gradient alcohol (75%, 80%, 90%, 95%, and
100%), cleared with butyl alcohol, embedded in paraffin,
sectioned horizontally along the modiolus, and stained
with hematoxylin and eosin (HE). Pathological changes
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cochleae were counted under a light microscope.
Prior to the electron microscope analysis, the cochleae
were fixed with 2.5% glutaraldehyde phosphate for 6 h
at 4°C. After fixation, the tissues were decalcified with
10% tetrasodium EDTA in PBS (pH = 7.4) for 1 wk.
The tissues were then fixed with 1% osmium tetroxide
for 15 min, dehydrated with gradient alcohol (50%, 70%,
80%, 90%, 95%, and 100%) and acetone (90% and 100%),
embedded in Epon 812, polymerized in the aggregator
for 24 h at 37°C and for 24 h at 60°C, sectioned hori-
zontally along the modiolus, and stained with 2% uranyl
acetate and lead citrate. The observed ultrastructural
changes were photographed.
In situ hybridization
A synthetic oligonucleotide probe (Shanghai Sangon
Biological Engineering Technology & Services Co., Ltd.,
China) with the following sequences were used: 5’-CCA-
GAC-TCT-CTT-TTC-TGA-GGG-CCC-TAG-ATT-3’
(exon 4 of the MCMV IE cDNA 1871-1900, GenBank
accession number M11788). It was labeled by 5’-tailing
with DIG-11-Dutp. The sections were dewaxed in water
with xylene and gradient alcohol (100%, 95%, 90%, 80%,
and 75%). Thereafter, the sections were treated with 3%
H2O2 for 10 min and protease K (20 ug/ml) for 20 min
at 37°C. Nonradioactive ISH was performed using the
Enhanced Sensitive ISH Detection Kit (POD) (MK1030,
Boster Biological Technology, Ltd., China) as specified
by the manufacturer. The ISH signal was colored with
DAB and observed through a microscope.
Quantification of the staining intensity of MCMV IE
DNA was performed through image analysis. Gray scale
images of MCMV IE DNA staining were recorded using
an Olympus BH-2 digital camera. The HPIAS-1000
image program was used to analyze the images, and the
staining intensity of the MCMV IE DNA was calculated
as an optical density (OD) value.
Results
1. Infection of mouse fetuses by intraplacental MCMV
injection
To obtain an experimental animal model of intrauterine
MCMV infection-induced hearing loss, we performed
direct placental MCMV infection in mice fetuses at day
12.5 of gestation, a period of active neurogenesis. On day
18.5, we sacrificed part of the pregnant mice, and observed
the development and the congenital infection rate of the
fetuses. At day 18.5 of gestation, viral DNA amplification
using PCR (the electrophoretogram of the MCMV DNA is
shown in Figure 1) in the placenta was observed at 58.49%
(31/53). The infection rates of the brains, livers, lungs, and
kidneys of the fetuses from placentas injected with
MCMV were 37.74% (20/53), 32.08% (17/53), 22.64% (12/
53), and 22.64% (12/53), respectively. Fetuses infected in
these organs accounted for 37.74% (20/53) of the fetuses
with placental injection; the rate of fetal infection from the
infected placentas was 61.29% (19/31). These results sug-
gest that the direct injection of MCMV into the placenta
may efficiently cause fetal infection.
The developmental conditions of the fetuses can be seen
in Tables 1 and 2. The fetal loss rate (34.57%) and the
microcephalus rate (33.96%) of the experimental group
were both higher than those of the operation control
group (1.21% and 2.41%, respectively) and the blank con-
trol group (1.27% and 0%, respectively). The body length
and head circumference of the fetuses in the experimental
group were both shorter than those of the fetuses in the
other two groups, and the weight of the fetuses in the
Figure 1 PCR detection of MCMV genomic DNA in fetal organs
and placentas from pregnant mice whose placentas were
injected with MCMV, 3% FCS DMEM, or without injection.
Primers from exon 4 of the MCMV IE gene (GenBank accession
number M11788) were used, yielding a 700-bp product. A: Lanes 1-
4, DNA from the fetal organs or the placentas of pregnant mice
whose placentas were injected with MCMV; Lane 5, DNA from the
fetal organs or the placentas of pregnant mice whose placentas
were injected with 3% FCS DMEM; Lane 6, DNA from the fetal
organs or the placentas of pregnant mice without placental
injection; Lane 7, DNA from virus-containing culture fluid. B: DNA
sequence of PCR products from organs or placentas with placental
MCMV injection.
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in the other two groups. However, there was no significant
difference in the parameters between the operation control
group and the blank control group. All these data suggest
that placental injection itself is not related to fetal loss,
microcephalus, and the abnormal intrauterine physical
growth of the fetuses, but the direct injection of MCMV
into the placenta may increase the risks.
2. MCMV-induced hearing loss in infected mice
After placental injection, some of the fetuses were allowed
to develop in uterus, and they were naturally delivered. We
used ABR to investigate the baseline hearing threshold of
each offspring 28 d and 70 d after delivery. Thereafter, the
offspring were sacrificed. The mean SPL of the offspring
can be seen in Table 3. At 28 days from delivery, the mean
SPL of the experimental group was significantly higher
than that of the operation control group and the blank con-
trol group. Similarly, at 70 days after delivery, the mean
SPL of the experimental group was significantly higher
than that of the operation control group and the blank con-
trol group. However, at 28 days and 70 days after delivery,
there were no significant differences between mice in the
operation control group and the blank control group.
Furthermore, in all three groups, there were no significant
differences between 28-day-old and 70-day-old mice. The
results indicate that placental injection does not lead to
hearing loss in offspring; however, the direct injection of
MCMV into the placenta may cause hearing loss in off-
spring. The injury lasts for 70 days or even longer.
3. Spread of virus in the cochleae of offspring in the
experimental group
After the ABR tests, the cochleae were taken out sepa-
rately and processed into paraffin sections. We detected
MCMV DNA signals through ISH (Figure 2). Negative
ISH signals were observed in cultured cells without
probe and MCMV infection, and cultured cells without
MCMV infection; MCMV DNA signals were detected in
the cytoplasm and the nucleus of MCMV-infected cell-
climbing films as brown granules. This suggests the per-
fect specificity of the experiment. ISH revealed that
mice in the 28-day-old offspring group and the 70-day-
old offspring group had similar localizations of MCMV
DNA in the cochleae. MCMV DNA signals were
detected in spiral ganglion neurons and in the endo-
lymph area, such as in the stria vascularis and spiral
ligament, but not in the perilymph area. In all instances,
when the MCMV DNA signal was detected in the stria
vascularis and spiral ligament, it was also detected in
the spiral ganglion. MCMV DNA signals were detected
in 50% (16/32) of the cochleae of the 28-day-old mice
[50% (16/32) in the spiral ganglion neurons, 31.25% (10/
32) in the stria vascularis, and 25% (8/32) in the spiral
ligaments]. For the 70-day-old mice, the positive rate of
the cochleae was 38.24% (13/34), and the positive rates
of the spiral ganglion neurons, stria vascularis, and the
spiral ligaments were 38.24% (13/34), 17.65% (6/34), and
23.53% (8/34), respectively.
T h eO Dv a l u e so fM C M VD N As i g n a li nt h es p i r a l
ganglion neurons, stria vascularis, and spiral ligaments
of the 28-day-old mice were 0.2529 ± 0.1281, 0.3112 ±
0.0980, and 0.2770 ± 0.1148, respectively. For the 70-
day-old mice, the OD values of the areas were 0.4052 ±
0.2205, 0.3954 ± 0.2389, and 0.3258 ± 0.2063, respec-
tively. There were no significant differences among the
three sites in both age groups. The OD value of the
spiral ganglion neurons of the 70-day-old group was sig-
nificantly higher than that of the 28-day-old group.
Although the OD values of the stria vascularis and spiral
Table 1 Growth and developmental status of offspring
Gestational sac (12.5 d) Live fetuses (18.5 d) Fetal loss (18.5 d)
(absorption, abortion, and stillbirth)
Microcephalus (18.5 d)
No. No. Percentage (%) No. Percentage (%) No. Percentage (%)
Experimental group 81 53 65.43
1, 3 28 34.57
1, 3 18 33.96
1, 3
Operation control group 83 82 98.79
2 1 1.21
2 2 2.41
2
Blank control group 79 78 98.73 1 1.27 0 0
1p < 0.05, experimental group versus operation control group.
2p > 0.05, operation control group versus blank control group.
3p < 0.05, experimental group versus blank control group.
Table 2 Physical growth status of live offspring
No. of live fetuses Body length ( x ± s mm) Head circumference ( x ± s mm) Weight ( x ±sg )
Experimental group 53 25.28 ± 1.77
1, 3 22.09 ± 2.35
1,3 1.26 ± 0.11
1, 3
Operation control group 82 26.29 ± 1.70
2 23.98 ± 1.99
2 1.41 ± 0.13
2
Blank control group 78 26.27 ± 1.82 24.37 ± 1.74 1.41 ± 0.12
1p < 0.01, experimental group versus operation control group.
2p > 0.05, operation control group versus blank control group.
3p < 0.01, experimental group versus blank control group.
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those of the 28-day-old group, there were, nevertheless,
no significant differences.
All these data suggest that MCMV are mainly located
i nt h es p i r a lg a n g l i o nn e u r o n s ,t h e ni nt h es t r i av a s c u -
laris and spiral ligaments of cochleae, respectively.
There were no significant differences in viral DNA con-
tent among the three sites in both 28-day-old and 70-
day-old mice, although viral DNA content, especially in
the spiral ganglia, increased with age (from 28 days to
70 days).
4. Histological changes of the cochleae of
MCMV-infected mice
According to the morphological results detected by light
microscope (Figure 3), spaces among spiral ganglion
neurons were widened, and the number of neurons was
reduced in both 28-day-old and 70-day-old groups.
However, there were no obvious inflammatory lesions.
In the 28-day-old group, there were 55.75 ± 2.357 and
60.50 ± 2.726 neuron cells in the MCMV DNA positive
and negative cochleae, respectively (P < 0.01). In the 70-
day-old group, there were 53.17 ± 1.169 and 57.50 ±
2.991 neuron cells in the MCMV DNA positive and
negative cochleae, respectively (P < 0.01). There were
fewer neuron cells in the MCMV DNA positive and
negative cochleae of 70-day-old mice than those of the
28-day-old mice (P < 0.050), especially in the MCMV
DNA positive cochleae.
Under an electron microscope (Figure 4), the primary
pathological changes in the 28-day-old mice were
located in the neurons of their spiral ganglia. The endo-
plasmic reticula and the ribosomes were bubbly swollen,
and their numbers were reduced. The number of lyso-
somes increased. No changes in the mitochondria were
observed. Gaps in the nuclear membranes increased.
Pathological changes in the 70-day-old mice were also
located in the neurons of their spiral ganglia. We found
that pathological changes in the 70-day-old mice were
more severe than in the 28-day-old mice. The neurons
showed diffused swelling, the physical component of
cytoplasm was significantly reduced, and a large number
of floc and vacuoles appeared. The residual endoplasmic
reticula and ribosomes were bubbly swollen. The num-
ber of lysosomes increased. Mitochondria were swollen
Table 3 The mean SPL of the offspring
28-days-old 70-days-old
No. Mean SPL No. Mean SPL
Experimental group 16 36.56 ± 9.44
1,3,4 17 40.29 ± 9.6
1, 3
Operation control group 20 19.75 ± 3.8
2,4 20 22.25 ± 4.13
2
Blank control group 20 19.25 ± 3.73
4 20 21.25 ± 3.93
1p < 0.01, experimental group versus operation control group.
2p > 0.05, operation control group versus blank control group.
3p < 0.01, experimental group versus blank control group.
4p > 0.05, 28-days-old versus 70-days-old.
Figure 2 In situ hybridization of MCMV DNA in the cochleae of
congenital MCMV-infected mice. The ISH signals are both
negative in cultured cells without probe and MCMV infection (A)
and cultured cells without MCMV infection (B); MCMV DNA signals
are detected in the cytoplasm and the nucleus of MCMV-infected
cultured cells as brown granules(C); MCMV DNA signals are negative
in the spiral ganglion neurons (D) and the stria vascularis (F) of the
control mice; MCMV DNA signals are detected in the spiral ganglion
neurons (E) and the stria vascularis (G) of the congenital MCMV-
infected mice.
Figure 3 Histology of the cochleae of normal fetuses and
fetuses with congenital MCMV infection under HE staining.A t
low magnification (×100), there are no obvious inflammatory lesions
in the cochleae of congenitally infected fetuses (B), but in contrast
to normal fetuses (A), the number of spiral ganglion neurons is
decreased, and the space among neurons is widened. At high
magnification (×400), in contrast to normal fetuses (C), the number
of spiral ganglion neurons in the cochleae of congenitally infected
fetuses is decreased (D), and the space among them is widened.
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ordered and fractured. Chromatin was condensed and
hyperchromatic.
The histological changes of the intrauterine MCMV-
infected cochleae of offspring suggest that the lesions
are mainly in the spiral ganglion neurons; with age, the
neural lesions progress and increase, and the number of
neurons decreases while exhibiting ongoing damage.
This is consistent with the trend of the cochlear viral
DNA content.
Discussion
HCMV is the most common pathogen causing congeni-
tal infection worldwide. Although congenital HCMV
infection can cause encephalopathy, along with cogni-
tive, motor, auditory, or visual impairments, SNHL
remains the most frequent sequela of congenital HCMV
infection, and it is usually the only sequela in asympto-
matic children [7]. Congenital HCMV infection-induced
SNHL affects 22% to 65% of symptomatic infants and
6% to 23% of asymptomatic infants [22-24]. Epidemiolo-
gical evidence also suggests that congenital HCMV
infection is the leading cause of SNHL, and it is respon-
sible for approximately 15% to 25% of congenital
deafness in children [8-10]. HCMV-induced hearing loss
may be present at birth, or it may occur later in the first
years of life; the onset of hearing loss in over 55% of
children who have hearing loss is delayed after the new-
born period. The median age of the onset of hearing
loss for symptomatic and asymptomatic children with
delayed hearing loss is 33 months (range, 6-197 months)
and 44 months (range, 24-182 months), respectively.
Approximately, 50% of all children with HCMV-related
SNHL will experience progression or further deteriora-
tion of their hearing loss over time [8]. We also found
that congenital intrauterine HCMV infection remarkably
increases the incidence of brainstem auditry in 4-
month-old children. In asymptomatic infants, brainstem
auditry may be under-diagnosed at the early postnatal
stage because SNHL is progressive and it has a late
onset [5]. Hence, we cannot provide early intervention
for affected children. No effective medical or surgical
therapy can cure SNHL. Cochlear implants can restore
partial hearing; however, the ideal subjects of cochlear
implantation are those suffering from post-linguistic
deafness and the costs are so high, so the method is not
widely used in China. Hence, the linguistic and commu-
nication competence of patients with CMV or congeni-
tal infection-induced SHNL cannot develop well.
Therefore, it is very important to conduct an intensive
study on the pathogenesis of congenital HCMV infec-
tion-induced SNHL.
In one study, the pathology of the inner ears was
obtained from an infant who died of severe congenital
CMV infection [25]. There was severe labyrinthitis in
the vestibular endolymphatic system, especially in the
saccule and utricle, with minor involvement of the
cochlea, which was mainly manifested as hydrops at
the basal turn. Inclusion-bearing cells that contain the
CMV antigen were present on the endolymphatic sur-
face of the membranous walls, mainly in the saccule and
utricle. CMV was also isolated from the perilymph.
However, CMV was not isolated from the inner ear
fluid of a 14-year-old male who died of sequela of con-
genital cytomegalic inclusion disease [26]. An examina-
tion of the temporal bones revealed the chronic
pathology of both cochlear and vestibular tissues, with
endolymphatic hydrops in the basal turn of the cochlear
duct, whereas Reissner’s membrane was collapsed in the
more apical turns. In addition, strial atrophy and loss of
cochlear hair cells along the entire length of the basilar
membrane were observed.
A PCR study proved that HCMV DNA can be
detected in the perilymph of patients with SNHL [27].
To better understand the damage caused by CMV infec-
tion of the inner ear, as well as its consequence and
pathogenesis, experimental animal models should be
used. A study on labyrinthitis following congenital
Figure 4 Ultrastructure of the cochlear spiral ganglion neurons
of normal fetuses and fetuses with congenital MCMV infection
at different ages under electron microscope. Compared with the
normal 28-day-old pups (A), swollen endoplasmic reticula (yellow
arrow) and increased lysosomes (blue arrow) can be seen in the
spiral ganglion neurons of congenitally infected pups (B, C).
Compared with the normal 70-day-old pups (D), the spiral ganglion
neurons of congenitally infected pups (E, F) show diffused swelling,
the physical component of the cytoplasm has disappeared, and a
large number of floc and vacuoles has appeared. The number of
lysosomes has increased. The chromatins appear condensed and
hyperchromatic.
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GPCMV into 5-week-pregnant guinea pigs, has demon-
strated that congenital GPCMV infection results in
severe labyrinthitis in fetuses. GPCMV-infected cells
were detected in the perilymph area and spiral ganglion,
but not in the endolymph area and the hair cells [17].
Now, by autopsy and animal models, it has been vali-
dated that congenital HCMV infection-induced SNHL is
closely related to lesions in the inner ear, but the speci-
fic mechanism remains unclear.
The guinea pig model is the best animal model to be
used in the study of congenital CMV infection, and conge-
nital infection can lead to labyrinthitis in fetuses. However,
the lack of available guinea pig immunological reagents
suggests that animal models are not very suitable in inves-
tigating the mechanism of hearing loss. Nevertheless,
mouse, the most widely used experimental animal, has a
lot of available reagents. Although the three-cell-thick tro-
phoblast layer of the murine placenta restrains the spread
of MCMV to the fetus, the research of Dr. Y Tsutsui. [19]
showed that the direct injection of MCMV into the pla-
centa can cause congenital MCMV infection.
We performed direct placental MCMV infection in
mice fetuses at day 12.5 of gestation, a period of active
neurogenesis. The mice were sacrificed six days later. We
chose to inject the virus into the placentas at day 12.5 for
several reasons: (a) early blastocyst and ES cells are
refractory to MCMV infection until day 7.5 [28]; (b) it is
much easier to perform abortion if we make the injection
before day 12.5 because the placenta is so small; (c) day
12.5 is a period of active neurogenesis. We observed the
conditions and the development of the intrauterine infec-
tion. We found that 58.49% of the placentas and 37.73%
of the fetuses were infected; the rate of fetal infection
from the infected placentas was 58.06%. As observed,
among the organs infected by MCMV, the brain tissue
was the organ most sensitive to MCMV, with the highest
incidence (37.73%) of infections, followed by the liver
(32.07%), lung (22.64%), and kidney (22.64%). Essentially,
our observations in this study are consistent with pre-
viously reported results [19]. We also observed the devel-
opmental conditions of the fetuses. Both the fetal loss
rate and the microcephalus rate of the offspring from pla-
centas inoculated with MCMV increased, and the body
length, head circumference, and weight of the fetuses
decreased. However, the inoculation of placentas with
t h es a m ed o s eo f3 %F C SD M E Mh a dn os i g n i f i c a n t
adverse effect on offspring. These results indicate that
the direct injection of MCMV into the placenta may effi-
ciently cause fetal infection and disturb the intrauterine
development of fetuses, but the inoculation itself has no
obvious adverse effects on offspring. Therefore, the appli-
cation of placental MCMV inoculation method has been
successfully established through the mouse model.
We applied the murine model of intrauterine MCMV
infection to study cochlear infection, the postnatal histo-
logical changes caused by the infection, and the auditory
functions of offspring. ISH demonstrated that MCMV
DNA signals can be detected in the cochleae of 28-day-
and 70-day-old mice, and are mainly located in spiral
ganglion neurons, and then in the stria vascularis and
spiral ligaments, respectively, but not in the perilymph
area. We did not observe significant inflammatory
changes in the cochleae of mice across different ages.
This is inconsistent with the findings of Katano et al
[18]. Such inconsistency is probably due to differences
in experimental methods and in the age of offspring
used in the experiments. With increasing age, the
inflammatory response of cochleae disappears. We
further observed the pathological changes of the infected
spiral ganglion neurons and found that the infection sig-
nificantly decreases the number of neurons and signifi-
cantly changes the ultrastructures of neurons (e.g., there
is swelling of the endoplasmic reticula, ribosomes, and
mitochondria). Moreover, with increasing age, the num-
ber of neurons remarkably decreases and ultrastructural
lesions in some neurons become much more severe.
This is consistent with the finding that the hearing level
of offspring in the experimental group decreased and
worsened with age. However, across different ages, the
hearing level of offspring in the operation control group
was equal to that of offspring in the blank control
group. All the data demonstrate that the direct injection
of MCMV to the placenta may cause MCMV infection
of the cochleae of offspring, which leads to hearing
impairment. However, the injury is not related to pla-
cental injection itself. It may be closely related to the
infection of the spiral ganglion neurons, to the reduction
in the number of neurons, and to ultrastructural lesions
of the neurons. Pathological changes of the spiral gang-
lion neurons will inevitably affect their protein synthesis
and secretion functions, leading to the interruption of
the auditory pathway, which may be the major cause of
SNHL through congenital infection. In the future, we
will further study the mechanisms and possible treat-
ment of congenital CMV infection-induced hearing loss
using the same animal model.
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